My lab work generated lots of waste. Here’s how we reduced our footprint | Science | AAAS science.org/content/articl…

March 2024 | RBP-ReguNet Newsletter 🌟 Welcome to our inaugural newsletter for the RBP-ReguNet Project, funded by the European Union's Marie Skłodowska-Curie Actions! linkedin.com/posts/rbp-regu…

Last night, warming up for the first MSCA-DN RBP-ReguNet Project in-person meeting in Santiago de Compostela! Thank you all for coming!

During this Mid-Term Check meeting of the MSCA-DN RBP-ReguNet project, DCs' presentations are triggering a lot of interesting questions from their supervisors! They are already showing very high research level!

Esto es lo más importante que puedes leer hoy... 👇

💚 Únete al #EquipoCiMUS y colabora!!! Te esperamos este domingo 19 en la carrera solidaria #NiñosSinCáncerCity en Madrid! ⤵️ Fundación OC Contra el Cáncer Contra el Cáncer Investigación USC Pablo Aguiar Fernández

🎓A Universidade de Santiago súmase ao manifesto da CRUE con motivo do Día Internacional da Convivencia en Paz

Hello network! Check on this interesting webinar organized by The Non-Conformist Scientist: The second webinar of the 'Career Paths in Science' series is almost here! The topic is 'Academia vs Industry'! Register here: lnkd.in/dMqj2jsb

#CiMUSseminar | Glad to welcome this Friday Dr. Antonio Zorzano, group leader at IRB Barcelona. 🗣️"The thousand metabolic faces of mitochondria" 🗓️24/05/2024 🕐13:00 h 📍Theatre Room Hosted by PI Ashwin Woodhoo Lab

💡 Les cellules CAR-T sont en plein essor dans le traitement des cancers et au cœur de #CellAction, nouvelle plateforme de l’Institut Curie. Mise en lumière de ces médicaments qui révolutionnent la prise en charge du #cancer dans un reportage Le Figaro ↘️ sante.lefigaro.fr/medecine/les-c…

Celebrate #EMBL50 with us! 🎉 In June, we're celebrating EMBL science! What did you discover while at EMBL? How did EMBL shape your future research? Use #EMBL50 & tag @EMBL to tell us how the knowledge, skills, and connections from EMBL influenced your science.

🚀 Vaccin contre le cancer : l’Institut Curie annonce la création de la start-up Cereus Biosciences La société s’appuie sur la bio-informatique et l'immunologie pour révolutionner le traitement du cancer en développant des vaccins accessibles à tous. 👉 curie.fr/actualite/inno…

🔹Today's #CiMUSseminar at 1 pm: 🗣️ Dr. Mariana Astiz (Mariana Astiz), Ikerbasque researcher at Ʌʗʜʋʗɑɼɼʘ: 'Circadian system development and antenatal glucocorticoids' Hosted by GliaTime Lab (Circadian and Glial Biology Lab)

Worktime reductions (mainly the 4-day week) are a hot topic in public debate 🔥 Do we actually work more or less than in the past? Which segments of the workforce work shorter and longer hours? What are the main diffs across countries in this regard? 👉publications.jrc.ec.europa.eu/repository/han…

🔬 157 years ago, a brilliant scientist was born. A woman of "firsts", Marie Curie was the first woman to receive a The Nobel Prize and left behind her an invaluable scientific and moral legacy in the fight against #cancer. © Musée Curie

🗞️ New RBP-ReguNet Interview! 🧪🔥We are pleased to speak with Sidhant, an excellent RBP-ReguNet researcher currently completing his PhD at the Institut Curie in Paris under Prof. Stephan Vagner's supervision. ⭐Check the interview on our website! rbp-regunet.eu/interview-with…

The RBP-ReguNet consortium is meeting in Paris for an exciting review and scientific session hosted by Institut Curie!

It was fantastic to share some wonderful moments in Paris with the team!

For the month of July get to know Amina, PhD student from the MSCADN RBP-ReguNET Network. Amina joined Immagina in the beginning of last year and integrated the R&D team since 👩‍🔬🔬 Learn more about her 👇 #employeespotlight #ribosome #RNAbindingprotein

Comentando en EL PAÍS, con Andreea Ciudin, un excelente estudio publicado en nature que aporta más evidencia #científica sobre la #biologia de la #obesidad. #Epigenética #inflamacion #inmunidad #senescencia elpais.com/ciencia/2025-0… SEEDO Instituto de Invest. Sanitaria de Santiago (IDIS) CIBEROBN